Literature DB >> 12003456

Response styles among patients with minor depression and dysthymia in primary care.

Karen B Schmaling1, Sona Dimidjian, Wayne Katon, Mark Sullivan.   

Abstract

Ruminative responses to depression have predicted duration and severity of depressive symptoms. The authors examined how response styles change over the course of treatment for depression and as a function of type of treatment. They also examined the ability of response styles to predict treatment outcome and status at follow-up. Primary care patients (n = 96) with dysthymia or minor depression were randomly assigned to problem-solving therapy, paroxetine, or placebo. Patients' depressive symptoms and rumination, but not distraction, decreased over time. Pretreatment rumination and distraction were associated with more depressive symptoms at the conclusion of treatment; the latter finding was not consistent with the response style theory of depression. Results are discussed in terms of their implications for this theory.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003456     DOI: 10.1037//0021-843x.111.2.350

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  35 in total

1.  Depressed Adolescents' Pupillary Response to Peer Acceptance and Rejection: The Role of Rumination.

Authors:  Lindsey B Stone; Jennifer S Silk; Greg J Siegle; Kyung Hwa Lee; Laura R Stroud; Eric E Nelson; Ronald E Dahl; Neil P Jones
Journal:  Child Psychiatry Hum Dev       Date:  2016-06

Review 2.  Constructive and unconstructive repetitive thought.

Authors:  Edward R Watkins
Journal:  Psychol Bull       Date:  2008-03       Impact factor: 17.737

Review 3.  The default mode network and recurrent depression: a neurobiological model of cognitive risk factors.

Authors:  Igor Marchetti; Ernst H W Koster; Edmund J Sonuga-Barke; Rudi De Raedt
Journal:  Neuropsychol Rev       Date:  2012-05-09       Impact factor: 7.444

4.  A measure of cognitions specific to seasonal depression: Development and validation of the Seasonal Beliefs Questionnaire.

Authors:  Kelly J Rohan; Jonah Meyerhoff; Sheau-Yan Ho; Kathryn A Roecklein; Yael I Nillni; Joel J Hillhouse; Michael J DeSarno; Pamela M Vacek
Journal:  Psychol Assess       Date:  2019-03-28

5.  White matter abnormalities predict residual negative self-referential thinking following treatment of late-life depression with escitalopram: A preliminary study.

Authors:  Lindsay W Victoria; George S Alexopoulos; Irena Ilieva; Aliza T Stein; Matthew J Hoptman; Naib Chowdhury; Matteo Respino; Sarah Shizuko Morimoto; Dora Kanellopoulos; Jimmy N Avari; Faith M Gunning
Journal:  J Affect Disord       Date:  2018-09-11       Impact factor: 4.839

6.  Cognitive Change across Cognitive-Behavioral and Light Therapy Treatments for Seasonal Affective Disorder: What Accounts for Clinical Status the Next Winter?

Authors:  Maggie Evans; Kelly J Rohan; Lilya Sitnikov; Jennifer N Mahon; Yael I Nillni; Kathryn Tierney Lindsey; Pamela M Vacek
Journal:  Cognit Ther Res       Date:  2013-12

7.  EFFECTS OF RUMINATION AND INITIAL SEVERITY ON REMISSION TO COGNITIVE THERAPY FOR DEPRESSION.

Authors:  Neil P Jones; Greg J Siegle; Michael E Thase
Journal:  Cognit Ther Res       Date:  2008-08-01

8.  Cognitive behavioral therapy for depression changes medial prefrontal and ventral anterior cingulate cortex activity associated with self-referential processing.

Authors:  Shinpei Yoshimura; Yasumasa Okamoto; Keiichi Onoda; Miki Matsunaga; Go Okada; Yoshihiko Kunisato; Atsuo Yoshino; Kazutaka Ueda; Shin-ichi Suzuki; Shigeto Yamawaki
Journal:  Soc Cogn Affect Neurosci       Date:  2013-01-17       Impact factor: 3.436

Review 9.  An attentional scope model of rumination.

Authors:  Anson J Whitmer; Ian H Gotlib
Journal:  Psychol Bull       Date:  2012-12-17       Impact factor: 17.737

Review 10.  The bright side of being blue: depression as an adaptation for analyzing complex problems.

Authors:  Paul W Andrews; J Anderson Thomson
Journal:  Psychol Rev       Date:  2009-07       Impact factor: 8.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.